Natural Products: A Promising Therapeutics for Targeting Tumor Angiogenesis

Ruyi Li1, Xin Song2, Yanan Guo3,4

  • 1Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Frontiers in Oncology
|November 8, 2021
PubMed

Insights

Natural products offer a promising avenue for anti-cancer therapy by targeting tumor angiogenesis. This review details natural agents that inhibit blood vessel formation, aiding drug development for cancer treatment.

Area of Science:

  • Oncology
  • Pharmacology
  • Natural Products Chemistry

Background:

  • Tumor-associated angiogenesis, driven by an imbalance of pro- and anti-angiogenic signals, is crucial for tumor growth, metastasis, and cancer stem cell proliferation.
  • Natural products are recognized for their potential in cancer therapy due to their low toxicity and cost-effectiveness.
  • Understanding established in vitro and in vivo angiogenesis models is essential for evaluating anti-cancer agents.

Purpose of the Study:

  • To review and classify natural products with anti-angiogenic properties.
  • To explore the mechanisms by which these natural agents target tumor angiogenesis-associated cytokines and apoptotic pathways.
  • To provide insights into natural product research for developing novel anti-tumor angiogenesis drugs.

Main Methods:

  • Literature review and classification of natural anti-angiogenic agents based on chemical structures (Polyphenols, Polysaccharides, Alkaloids, Terpenoids, Saponins).
  • Analysis of mechanistic principles of natural products in regulating angiogenesis-associated cytokines and apoptotic signaling pathways.
  • Summary of established in vitro and in vivo models for studying tumor angiogenesis.

Main Results:

  • Identification and categorization of various classes of natural products exhibiting anti-angiogenic effects.
  • Elucidation of the molecular mechanisms underlying the anti-angiogenic activity of these natural compounds.
  • Discussion of the relevance of different angiogenesis models in the context of natural product research.

Conclusions:

  • Natural products represent a valuable resource for developing targeted anti-cancer therapies by inhibiting tumor angiogenesis.
  • Further research into the mechanisms of action and chemical structures of these agents can accelerate drug discovery.
  • This review consolidates current knowledge, facilitating future development of natural product-based anti-angiogenic drugs.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.1K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
731
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.0K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.1K